TELA Bio Reports Q2 2026 Financial Results

What Happened
On August 10, 2026, TELA Bio, Inc. announced its financial results for the quarter ended June 30, 2026 via a press release. The company furnished that press release as Exhibit 99.1 to a Form 8-K under Item 2.02 (Results of Operations and Financial Condition).

Key Details

• Filing date: August 10, 2026 (Form 8-K furnished)
• Reporting period: Quarter ended June 30, 2026
• Exhibits: Press release furnished as Exhibit 99.1; interactive XBRL cover page included as Exhibit 104
• Form item: Item 2.02 — Results of operations and financial condition

Why It Matters
The 8-K provides the company’s latest quarterly earnings and operational results, which investors use to assess revenue, profitability, cash position, and near-term outlook. Retail investors should review the attached press release (Exhibit 99.1) for the specific financial figures, any management commentary, and updates that could affect TELA’s short- and medium-term valuation or investment thesis.